Moore C, Corden S, Sinha J, Jones R (November 2008). «Dry cotton or flocked respiratory swabs as a simple collection technique for the molecular detection of respiratory viruses using real-time NASBA». Journal of Virological Methods. 153 (2): 84–9. doi:10.1016/j.jviromet.2008.08.001. PMID18761378.
Chimenti C, Pieroni M, Frustaci A (April 2006). «Myocarditis: when to suspect and how to diagnose it in athletes». J Cardiovasc Med. Hagerstown. 7 (4): 301–6. doi:10.2459/01.JCM.0000219325.50622.93. PMID16645406.
Moses H, Brandes DW (September 2008). «Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis». Curr Med Res Opin. 24 (9): 2679–90. doi:10.1185/03007990802329959. PMID18694542. S2CID72997113.
Antoniou C, Stefanaki I, Stratigos A, և այլք: (April 2007). «The Greek experience with efalizumab in psoriasis from a university dermatologic hospital». Br J Dermatol. 156 Suppl 2: 12–6. doi:10.1111/j.1365-2133.2007.07764.x. PMID17371318. S2CID25324493.
«Case definitions». European Influenza Surveillance Scheme. 2005 թ․ դեկտեմբերի 12. Արխիվացված է օրիգինալից 2009 թ․ նոյեմբերի 12-ին. Վերցված է 2009 թ․ հուլիսի 15-ին.
Moore C, Corden S, Sinha J, Jones R (November 2008). «Dry cotton or flocked respiratory swabs as a simple collection technique for the molecular detection of respiratory viruses using real-time NASBA». Journal of Virological Methods. 153 (2): 84–9. doi:10.1016/j.jviromet.2008.08.001. PMID18761378.
Chimenti C, Pieroni M, Frustaci A (April 2006). «Myocarditis: when to suspect and how to diagnose it in athletes». J Cardiovasc Med. Hagerstown. 7 (4): 301–6. doi:10.2459/01.JCM.0000219325.50622.93. PMID16645406.
Moses H, Brandes DW (September 2008). «Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis». Curr Med Res Opin. 24 (9): 2679–90. doi:10.1185/03007990802329959. PMID18694542. S2CID72997113.
Antoniou C, Stefanaki I, Stratigos A, և այլք: (April 2007). «The Greek experience with efalizumab in psoriasis from a university dermatologic hospital». Br J Dermatol. 156 Suppl 2: 12–6. doi:10.1111/j.1365-2133.2007.07764.x. PMID17371318. S2CID25324493.
Moses H, Brandes DW (September 2008). «Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis». Curr Med Res Opin. 24 (9): 2679–90. doi:10.1185/03007990802329959. PMID18694542. S2CID72997113.
Antoniou C, Stefanaki I, Stratigos A, և այլք: (April 2007). «The Greek experience with efalizumab in psoriasis from a university dermatologic hospital». Br J Dermatol. 156 Suppl 2: 12–6. doi:10.1111/j.1365-2133.2007.07764.x. PMID17371318. S2CID25324493.
«Case definitions». European Influenza Surveillance Scheme. 2005 թ․ դեկտեմբերի 12. Արխիվացված է օրիգինալից 2009 թ․ նոյեմբերի 12-ին. Վերցված է 2009 թ․ հուլիսի 15-ին.
Loving, Nancy S (2006). All horse systems go: the horse owner's full-color veterinary care and conditioning resource for modern performance, sport, and pleasure horses. Trafalgar Square Publishing. ISBN9781570763267. OCLC61864306. page 439